These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16612422)

  • 21. The changing face of the HIV epidemic in Taiwan: a new challenge for public health policy strategies.
    Chen KT; Chang HL; Chen CT; Chen YA
    AIDS Patient Care STDS; 2009 Mar; 23(3):195-201. PubMed ID: 19866537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstacles to the development of prevention and public health policies in Argentina.
    Touzé G
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S372-5. PubMed ID: 14648450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
    Lert F; Kazatchkine MD
    Int J Drug Policy; 2007 Aug; 18(4):255-61. PubMed ID: 17689373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
    Duran S; Solas C; Spire B; Carrieri MP; Fuzibet JG; Costagliola D; Lacarelle B; Moatti JP;
    AIDS; 2001 May; 15(8):1075-7. PubMed ID: 11399998
    [No Abstract]   [Full Text] [Related]  

  • 25. Learning from HIV epidemics among injecting drug users.
    Jarlais DC
    Int J Drug Policy; 2010 Mar; 21(2):97-9. PubMed ID: 20018500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.
    Palepu A; Tyndall MW; Li K; Yip B; O'Shaughnessy MV; Schechter MT; Montaner JS; Hogg RS
    J Urban Health; 2003 Dec; 80(4):667-75. PubMed ID: 14709714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing drug users' adherence to HIV treatment: results of a peer-driven intervention feasibility study.
    Broadhead RS; Heckathorn DD; Altice FL; van Hulst Y; Carbone M; Friedland GH; O'Connor PG; Selwyn PA
    Soc Sci Med; 2002 Jul; 55(2):235-46. PubMed ID: 12144138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brazilian response to the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic among injection drug users.
    Mesquita F; Doneda D; Gandolfi D; Nemes MI; Andrade T; Bueno R; Piconez e Trigueiros D
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S382-5. PubMed ID: 14648452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Highly active antiretroviral therapy for injection drug users: physician-recommended strategies for enhanced adherence.
    Vassilev ZP; Hagan H
    Antivir Ther; 2004 Jun; 9(3):461. PubMed ID: 15259910
    [No Abstract]   [Full Text] [Related]  

  • 30. Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death.
    Vlahov D; Celentano DD
    Cad Saude Publica; 2006 Apr; 22(4):705-18. PubMed ID: 16612417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and antiretroviral therapy in injection drug users.
    Sherer R
    JAMA; 1998 Aug; 280(6):567-8. PubMed ID: 9707152
    [No Abstract]   [Full Text] [Related]  

  • 32. How Ukraine is tackling Europe's worst HIV epidemic.
    Hurley R
    BMJ; 2010 Jul; 341():c3538. PubMed ID: 20627980
    [No Abstract]   [Full Text] [Related]  

  • 33. Setting district-based annual targets for HAART and PMTCT - a first step in planning effective intervention for the HIV/AIDS epidemic.
    Barker PM; Venter F
    S Afr Med J; 2007 Oct; 97(10):916-7. PubMed ID: 18027467
    [No Abstract]   [Full Text] [Related]  

  • 34. Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level.
    van Asten LC; Boufassa F; Schiffer V; Brettle RP; Robertson JR; Hernández Aguado I; McMenamin J; Zangerle R; Fontanet A; Coutinho RA; Prins M
    Eur J Public Health; 2003 Dec; 13(4):347-9. PubMed ID: 14703322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of barriers and facilitators of HIV treatment among injection drug users.
    Wood E; Kerr T; Tyndall MW; Montaner JS
    AIDS; 2008 Jul; 22(11):1247-56. PubMed ID: 18580603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality among urban drug users and the impact of highly active antiretroviral therapy.
    Celentano DD
    Clin Infect Dis; 2005 Sep; 41(6):873-4. PubMed ID: 16107988
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV treatment, injection drug use, and illicit drug policies.
    Wood E; Kerr T; Montaner JS
    Lancet; 2007 Jul; 370(9581):8-10. PubMed ID: 17617253
    [No Abstract]   [Full Text] [Related]  

  • 38. Can HIV epidemics among injection drug users be prevented?
    Strathdee SA; van Ameijden EJ; Mesquita F; Wodak A; Rana S; Vlahov D
    AIDS; 1998; 12 Suppl A():S71-9. PubMed ID: 9632987
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDS. Asia grapples with unexpected wave of HIV infections.
    Normile D
    Science; 2009 Nov; 326(5957):1174. PubMed ID: 19965441
    [No Abstract]   [Full Text] [Related]  

  • 40. [HIV epidemic in intravenous drug users--is Finland behind or ahead of other Western countries?].
    Leinikki P
    Duodecim; 2000; 116(1):55-60. PubMed ID: 11764461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.